ATF Medical Launches Pressure Injury Prevention and Intervention Program

ATF Medical has introduced its Pressure Injury Prevention and Intervention (PIPI) program to make sure that everyone involved in a workers’ compensation case has the information needed to prevent or properly treat pressure injuries, also known as wounds.

“There is a large body of information from credible nursing, rehabilitation, and equipment manufacturers about pressure injuries, but it is not all in one place, and not customized to the individual and circulated to all the providers who need it,” said ATF Medical’s Director of Rehab Technology Edwina Murphy, OTR, ATP.

The PIPI program reviews clients’ claims to identify injured workers at risk of developing pressure injuries and recommends ways to avoid them. When wounds already exist, ATF Medical’s professionals evaluate the injured worker’s condition and environment and uses pressure mapping systems for chairs and mattresses to detect pressure points.

“Pressure mapping helps identify a seat or mattress issue, often something that can be easily and inexpensively adjusted,” Murphy explained. “It’s an eye-opening educational tool. When injured people can see how relieving pressure affects the colors on the map, they’re more apt to comply with relief techniques and other self-management guidance.”

ATF Medical designs a customized pressure management program for the injured worker, synthesizing relevant treatment protocols, durable medical equipment data, and educational materials, and shares it with the injured worker, providers, and the claim representative. The report recommends solutions, such as pressure relief schedules to increase circulation or obtaining power-assisted tilt for a person who cannot move him or herself.

“Our program is designed to avoid and reduce costs through proper communication, coordination and accountability,” Murphy said. For more information on the ATF Medical Pressure Injury and Prevention Program, please contact Murphy at emurphy@atfmedical.com.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.